Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Amortization of Deferred Charges (2022 - 2026)

Repligen's (RGEN) quarterly Amortization of Deferred Charges came in at $4.5 million in Q2 2026, up 8.3% year-over-year from $4.1 million in Q2 2025, and up 2.04% quarter-over-quarter from $4.4 million in Q1 2026.

Analysis

Repligen (RGEN) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends

Repligen (RGEN) has reported Amortization of Deferred Charges for 5 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 8.3% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $17.3 million, a 31.29% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, up 6.79% from the prior year.
  • Amortization of Deferred Charges was $4.5 million for Q2 2026 at Repligen, up from $4.4 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $4.5 million in Q2 2026 and troughed at $452000.0 in Q1 2022.
  • A 5-year average of $2.4 million and a median of $2.5 million in 2023 frame the typical range for Amortization of Deferred Charges.
  • Across the five-year window, Amortization of Deferred Charges rose 0.88% in 2023 and jumped 268.37% in 2024, its largest moves.
  • Over 5 years, Amortization of Deferred Charges stood at $455000.0 in 2022, then surged by 136.26% to $1.1 million in 2023, then jumped by 268.37% to $4.0 million in 2024, then gained by 8.23% to $4.3 million in 2025, then grew by 4.08% to $4.5 million in 2026.
  • The last three Amortization of Deferred Charges figures came in at $4.5 million (Q2 2026), $4.4 million (Q1 2026), and $4.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.46 Mn
Mar 31, 2026 4.37 Mn
Dec 31, 2025 4.29 Mn
Sep 30, 2025 4.20 Mn
Jun 30, 2025 4.12 Mn
Mar 31, 2025 4.04 Mn
Dec 31, 2024 3.96 Mn
Dec 31, 2023 1.08 Mn
Sep 30, 2023 459,000.00
Jun 30, 2023 457,000.00
Mar 31, 2023 457,000.00
Sep 30, 2022 455,000.00
Jun 30, 2022 453,000.00
Mar 31, 2022 452,000.00